ARTICLE | Clinical News
BCV vaccine delivery system: Phase I
February 20, 2001 8:00 AM UTC
In a study of 60 healthy volunteers, SIGA said that a single dose of its BCV vaccine delivery system was well tolerated and colonized oral and nasal cavities. S. gordonii, which SIGA said is a normal ...